Oses et al. [178] demonstrated that the preconditioning of human AD-MSCs, with the iron chelator deferoxamine (DFX), increased the expression of the hypoxia inducible factor 1 alpha (HIF-1α), without effects on MSC morphology and survival. The gene discussed is HIF1A; the disease is Alzheimer disease.